Suppr超能文献

易于快速表达和天然提取恶性疟原虫 Duffy 结合蛋白片段的方法。

Easy and fast method for expression and native extraction of Plasmodium vivax Duffy binding protein fragments.

机构信息

Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50 No. 26-20, Bogotá, DC, Colombia.

Livestock Sciences Faculty, Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Calle 222 No. 55-37, Bogotá, DC, Colombia.

出版信息

Malar J. 2018 Feb 8;17(1):76. doi: 10.1186/s12936-018-2216-6.

Abstract

BACKGROUND

The Plasmodium vivax Duffy binding protein (PvDBP) has been the most studied ligand binding human reticulocytes to date. This molecule has a cysteine-rich domain in region II (RII) which has been used as control for evaluating the target cell binding activity of several parasite molecules. However, obtaining rPvDBP-RII in a soluble form using the Escherichia coli expression system usually requires laborious and time-consuming steps for recovering the molecule's structure and function, considering it is extracted from inclusion bodies. The present study describes an easy and fast method for expressing and obtaining several PvDBP fragments which should prove ideal for use in protein-cell interaction assays.

RESULTS

Two PvDBP encoding regions (rii and riii/v) were cloned in pEXP5-CT vector and expressed in E. coli and extracted from the soluble fraction (rPvDBP-RII and rPvDBP-RIII/V) using a simple freezing/thawing protocol. After the purification, dichroism analysis enabled verifying high rPvDBP-RII and rPvDBP-RIII/V secondary structure α-helix content, which was lowered when molecules were extracted from inclusion bodies (rPvDBP-RII and rPvDBP-RIII/V) using a denaturing step. Interestingly, rPvDBP-RII, but not rPvDBP-RII, bound to human reticulocytes, while rPvDBP-RIII/V and rPvDBP-RIII/V bound to such cells in a similar way to negative control (cells incubated without recombinant proteins).

CONCLUSIONS

This research has shown for the first time how rPvDBP-RII can be expressed and obtained in soluble form using the E. coli system and avoiding the denaturation and refolding steps commonly used. The results highlight the usefulness of the rPvDBP-RIII/V fragment as a non-binding control for protein-cell target interaction assays. The soluble extraction protocol described is a good alternative to obtain fully functional P. vivax proteins in a fast and easy way, which will surely prove useful to laboratories working in studying this parasite's biology.

摘要

背景

迄今为止,恶性疟原虫(Plasmodium vivax)的达菲结合蛋白(PvDBP)是研究得最多的配体结合人网织红细胞的蛋白。该分子在区域 II(RII)有一个富含半胱氨酸的结构域,该结构域已被用作评估几种寄生虫分子靶细胞结合活性的对照。然而,使用大肠杆菌表达系统获得可溶性形式的 rPvDBP-RII 通常需要费力且耗时的步骤来恢复分子的结构和功能,因为它是从包涵体中提取的。本研究描述了一种表达和获得多个 PvDBP 片段的简便快速方法,该方法对于用于蛋白-细胞相互作用测定应该非常理想。

结果

将两个 PvDBP 编码区(rii 和 riii/v)克隆到 pEXP5-CT 载体中,并在大肠杆菌中表达,然后使用简单的冻融方案从可溶性部分(rPvDBP-RII 和 rPvDBP-RIII/V)中提取。纯化后,圆二色性分析验证了高 rPvDBP-RII 和 rPvDBP-RIII/V 的二级结构α-螺旋含量,当用变性步骤从包涵体(rPvDBP-RII 和 rPvDBP-RIII/V)中提取分子时,该含量会降低。有趣的是,rPvDBP-RII 但不是 rPvDBP-RII 与人类网织红细胞结合,而 rPvDBP-RIII/V 和 rPvDBP-RIII/V 与这些细胞的结合方式与阴性对照(未孵育重组蛋白的细胞)相似。

结论

本研究首次表明如何使用大肠杆菌系统以可溶性形式表达和获得 rPvDBP-RII,同时避免了常用的变性和复性步骤。结果突出了 rPvDBP-RIII/V 片段作为蛋白-细胞靶相互作用测定中非结合对照的有用性。所描述的可溶性提取方案是快速简便地获得完全功能性恶性疟原虫蛋白的一种很好的替代方法,肯定会对研究这种寄生虫生物学的实验室有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验